• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Moves Lower; Dollar General Earnings Beat Estimates

    12/7/23 12:18:51 PM ET
    $BNED
    $CYN
    $DG
    $PHIO
    Other Specialty Stores
    Consumer Discretionary
    EDP Services
    Technology
    Get the next $BNED alert in real time by email

    U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday.

    The Dow traded up 0.06% to 36,077.32 while the NASDAQ rose 1.09% to 14,301.04. The S&P 500 also rose, gaining, 0.66% to 4,579.41.

    Check This Out: Top 5 Tech Stocks You May Want To Dump In December

     

    Leading and Lagging Sectors

     

    Communication services shares rose by 3.1% on Thursday.

    In trading on Thursday, health care shares fell by 0.4%.

     

    Top Headline

     

    Dollar General Corp (NYSE:DG) reported better-than-expected third-quarter results.

    Dollar General reported third-quarter FY23 sales growth of 2.4% year-on-year to $9.69 billion, beating the analyst consensus estimate of $9.65 billion. EPS of $1.26 beat the consensus estimate of $1.19.

     

    Equities Trading UP

     

    Save Foods, Inc. (NASDAQ:SVFD) shares shot up 200% to $6.45 after the company highlighted targeting of US carbon credit market following acquisition of majority ownership in newly- formed Nitrousink Ltd.

    Shares of Cyngn Inc. (NASDAQ:CYN) got a boost, shooting 87% to $0.4569 after the company announced the issuance of a new patent, US-11,837,089-B2, for the autonomous vehicle (AV) and driving solutions.

    Barnes & Noble Education, Inc. (NYSE:BNED) shares were also up, gaining 29% to $1.3499 following upbeat quarterly earnings.

     

    Equities Trading DOWN

     

    Troika Media Group, Inc. (NASDAQ:TRKA) shares dropped 74% to $0.4995 after the company announced it filed for Chapter 11.

    Shares of ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) were down 37% to $1.35 after the company priced its $5 million public offering.

    Phio Pharmaceuticals Corp. (NASDAQ:PHIO) was down, falling 44% to $0.8901 as the company announced exercise of warrants for $2.8 million gross proceeds.

    Also Check This Out: Bitcoin, Ethereum Fall Following Jobless Claims Data; BitTorrent Becomes Top Loser

     

    Commodities

     

    In commodity news, oil traded up 0.8% to $69.92 while gold traded down 0.5% at $2,038.70.

    Silver traded down 0.6% to $24.09 on Thursday while copper rose 1% to $3.7730.

     

    Euro zone

     

    European shares were lower today. The eurozone’s STOXX 600 fell 0.33%, London’s FTSE 100 fell 0.13% while Spain’s IBEX 35 Index fell 1.27% The German DAX fell 0.12% French CAC 40 fell 0.14%, while Italy’s FTSE MIB Index fell 0.77%.

    The Eurozone economy shrank by 0.1% in the third quarter versus a revised 0.1% expansion in the prior three-month period. The number of employed persons in the Eurozone increased by 0.2% from the earlier quarter to 168.7 million in the third quarter.

    French trade deficit shrank to €8.6 billion in October versus a revised €8.87 billion in the prior month, while current account deficit increased to €2.9 billion in October from a revised €2.8 billion a month ago. Industrial production in Germany declined 0.4% month-over-month for October. The Halifax House Price Index fell by 1.0% year-over-year during November.

     

    Asia Pacific Markets

     

    Asian markets closed lower on Thursday, with Japan’s Nikkei 225 falling 1.76%, Hong Kong’s Hang Seng Index falling 0.71% and China’s Shanghai Composite Index falling 0.09%. India’s S&P BSE Sensex, meanwhile, fell 0.19%.

    The index of coincident economic indicators in Japan rose to 115.9 in October versus a revised 115.7 in the previous month, while index of leading economic indicators fell to 108.7 in October versus a revised 109.3 a month ago. China's trade surplus widened to $68.39 billion in November from $66.49 billion in the year-ago period.

     

    Economics

     

    U.S. initial jobless claims rose by 1,000 to 220,000 in the week ending Dec. 2, compared to market estimates of 222,000.

    U.S.-based employers announced plans to reduce 45,510 jobs during November.

    The Manheim Used Vehicle Value Index for the U.S. declined 2.1% month-over-month in November versus a 2.3% decline in October.

    U.S. wholesale inventories declined by 0.4% month-over-month in October versus preliminary estimate of a 0.2% decline.

    U.S. natural-gas supplies fell 117 billion cubic feet last week, the EIA said.

    Now Read This: 'I Like It Very Much': Jim Cramer Bullish On This Financial Stock Up 75% YTD

    Get the next $BNED alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNED
    $CYN
    $DG
    $PHIO

    CompanyDatePrice TargetRatingAnalyst
    Dollar General Corporation
    $DG
    3/13/2026$130.00 → $140.00Market Perform
    Telsey Advisory Group
    Dollar General Corporation
    $DG
    2/17/2026$111.00Neutral → Sell
    Rothschild & Co Redburn
    Dollar General Corporation
    $DG
    1/8/2026$170.00Hold → Buy
    Deutsche Bank
    Dollar General Corporation
    $DG
    12/15/2025$166.00Neutral → Overweight
    Analyst
    Dollar General Corporation
    $DG
    12/5/2025$123.00 → $130.00Market Perform
    Telsey Advisory Group
    Dollar General Corporation
    $DG
    12/4/2025Accumulate → Buy
    Gordon Haskett
    Dollar General Corporation
    $DG
    9/18/2025$139.00Outperform
    Wolfe Research
    Dollar General Corporation
    $DG
    6/24/2025$116.00Buy → Neutral
    Goldman
    More analyst ratings

    $BNED
    $CYN
    $DG
    $PHIO
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Cyngn Inc.

    SCHEDULE 13G - Cyngn Inc. (0001874097) (Subject)

    4/22/26 9:01:55 AM ET
    $CYN
    EDP Services
    Technology

    Phio Pharmaceuticals Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Phio Pharmaceuticals Corp. (0001533040) (Filer)

    4/8/26 4:15:54 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Phio Pharmaceuticals Corp.

    424B5 - Phio Pharmaceuticals Corp. (0001533040) (Filer)

    4/8/26 4:13:18 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $CYN
    $DG
    $PHIO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, Pres. & CEO Bitterman Robert J bought $5,150 worth of shares (5,000 units at $1.03), increasing direct ownership by 2% to 291,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    1/2/26 4:05:06 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,100 worth of shares (5,000 units at $1.02), increasing direct ownership by 2% to 286,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    12/29/25 8:10:21 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chairman, Pres. & CEO Bitterman Robert J bought $5,700 worth of shares (5,000 units at $1.14), increasing direct ownership by 2% to 281,421 units (SEC Form 4)

    4 - Phio Pharmaceuticals Corp. (0001533040) (Issuer)

    11/24/25 12:54:10 PM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $CYN
    $DG
    $PHIO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Dollar General with a new price target

    Telsey Advisory Group reiterated coverage of Dollar General with a rating of Market Perform and set a new price target of $140.00 from $130.00 previously

    3/13/26 8:26:18 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Dollar General downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Dollar General from Neutral to Sell and set a new price target of $111.00

    2/17/26 8:12:52 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Dollar General upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Dollar General from Hold to Buy and set a new price target of $170.00

    1/8/26 8:21:13 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    $BNED
    $CYN
    $DG
    $PHIO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Elliott Anita C

    4 - DOLLAR GENERAL CORP (0000029534) (Issuer)

    4/3/26 10:34:12 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 4 filed by Wheeler Bryan D

    4 - DOLLAR GENERAL CORP (0000029534) (Issuer)

    4/3/26 10:33:07 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 4 filed by West Roderick J

    4 - DOLLAR GENERAL CORP (0000029534) (Issuer)

    4/3/26 10:32:26 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    $BNED
    $CYN
    $DG
    $PHIO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Barnes & Noble Education to Host Investor Day on June 25, 2026

    FLORHAM PARK, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE:BNED), ("Barnes & Noble Education," "BNED," "the Company," "we," "us," "our"), a leading solutions provider for the education industry, today announced it will host a virtual Investor Day on Thursday, June 25, 2026, broadcast live from the New York Stock Exchange. During the event, BNED's leadership team will present a comprehensive overview of the Company's strategy, key growth drivers, and financial outlook. The presentation will highlight BNED's focus on improving affordability and outcomes for students, expanding its First Day® programs, and enhancing its omnichannel campus retail model to bett

    4/23/26 8:30:00 AM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

    Live Presentation and Q&A: Wednesday, April 29, 2026 12 PM EDTKing of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities, followed by a live Q&A.Phio's lead clinical candidate, PH-762, is being evaluated as an intratumoral therapy in cutaneous squamous cell carcinoma (cSCC), mela

    4/23/26 7:00:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BetterInvesting™ Magazine Update on The Charles Schwab Corp. (NYSE: SCHW) and Dollar General Corp. (NYSE: DG)

    TROY, Mich., April 21, 2026 /PRNewswire/ -- Charles Schwab Corp.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers Charles Schwab (NYSE:SCHW) as worthy of further study and has named the company its "Stock to Study" for the June/July 2026 issue for investors' informational and educational use. The fundamental data is eye-opening; investors can view Charles Schwab's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/tr

    4/21/26 12:52:00 AM ET
    $DG
    $SCHW
    Department/Specialty Retail Stores
    Consumer Discretionary
    Investment Bankers/Brokers/Service
    Finance

    $BNED
    $CYN
    $DG
    $PHIO
    Leadership Updates

    Live Leadership Updates

    View All

    Dollar General Corporation Appoints Jerry W. "JJ" Fleeman Jr., as Chief Executive Officer

    Fleeman to succeed Todd Vasos as CEO effective January 1, 2027 Dollar General Corporation (NYSE:DG) today announced that its Board of Directors has appointed Jerry W. "JJ" Fleeman Jr., to succeed Todd Vasos as Chief Executive Officer (CEO) of Dollar General effective January 1, 2027. The Board intends to appoint Fleeman to serve as a director upon the effective date of the transition. To assist in the transition, Vasos will continue to serve as CEO until the effective date of the transition, at which time he will serve as Senior Advisor through April 2, 2027. Following the transition, Vasos is expected to remain a member of the Board. "On behalf of the Board of Directors, I want to ex

    3/24/26 9:00:00 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Barnes & Noble Education Reports Fiscal Third Quarter 2026 Financial Results

    BNC First Day Program Revenue Increases 32.1% Net Income of $6.7 Million and Adjusted EBITDA of $23.6 Million Company to Commence Dividend Program in First Quarter of Fiscal 2027 Virtual Investor Day Scheduled for June 25, 2026 FLORHAM PARK, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE:BNED), ("Barnes & Noble Education," "BNED," "the Company," "we," "us," "our"), a leading solutions provider for the education industry, today reported financial results for the fiscal third quarter ended January 31, 2026. Virtual Investor Day Barnes & Noble Education has scheduled a virtual investor day for June 25, 2026. Management will provide an overview of the Com

    3/10/26 4:15:00 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $BNED
    $CYN
    $DG
    $PHIO
    Financials

    Live finance-specific insights

    View All

    ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

    ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 billion.Inflammasome ASC Inhibitor IC 100 is a next generation drug designed for unparalleled control of disease-causing inflammation by (1) inhibiting multiple inflammasomes activated in numerous diseases, not just NLRP3, and (2) attenuating spread and perpetuation of inflammation by uniquely inhibiting ASC specks. Lead indication: Cardiometabolic conditions associated with obesityValue driving milestones: File IND Q4-2026; Phase 1 SAD read-out Q1-2027 Cholesterol Efflux Mediator VAR 200 is expected to be a disease-modifying renal drug by targeting unaddress

    3/31/26 5:05:00 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dollar General Corporation Reports Strong Fourth Quarter and Fiscal Year 2025 Results

    Provides Financial Guidance for Fiscal Year 2026 Dollar General Corporation (NYSE:DG) today reported financial results for its fourth quarter (13 weeks) and fiscal year (52 weeks) ended January 30, 2026 ("fiscal 2025"). Fourth Quarter Net Sales Increased 5.9% to $10.9 Billion; Fiscal Year Net Sales Increased 5.2% to $42.7 Billion Fourth Quarter Same-Store Sales Increased 4.3%; Fiscal Year Same-Store Sales Increased 3.0% Fourth Quarter Operating Profit Increased 106.1% to $606.3 Million; Fiscal Year Operating Profit Increased 28.6% to $2.2 Billion Fourth Quarter Diluted Earnings Per Share ("EPS") Increased 121.8% to $1.93; Fiscal Year Diluted EPS Increased 34.1% to $6.85 Ann

    3/12/26 6:50:00 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Cyngn Announces Date for 2025 Fourth Quarter and Year-End Financial Results

    MOUNTAIN VIEW, Calif., March 5, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) will announce its 2025 fourth quarter and year-end financial results for the period ended December 31, 2025, on Wednesday, March 25, 2026, after the close of market. The financial results will be available on the Cyngn website under "News & Events" at https://investors.cyngn.com/.  The Company will not host an earnings call.About CyngnCyngn develops and deploys autonomous vehicle technology for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges f

    3/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $BNED
    $CYN
    $DG
    $PHIO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Barnes & Noble Education Inc

    SC 13G/A - Barnes & Noble Education, Inc. (0001634117) (Subject)

    11/14/24 6:34:18 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by ZyVersa Therapeutics Inc.

    SC 13G/A - ZyVersa Therapeutics, Inc. (0001859007) (Subject)

    11/14/24 6:01:27 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dollar General Corporation

    SC 13G/A - DOLLAR GENERAL CORP (0000029534) (Subject)

    11/14/24 1:22:35 PM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary